Cue Biopharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
13.80
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.38
|
-0.31
|
0.07
|
18.42%
|
|
2022-06-30
|
-0.42
|
-0.37
|
0.05
|
11.90%
|
|
2022-03-31
|
-0.43
|
-0.44
|
-0.01
|
-2.33%
|
|
2021-12-31
|
-0.38
|
-0.25
|
0.13
|
34.21%
|
|
2021-09-30
|
-0.39
|
-0.41
|
-0.02
|
-5.13%
|
|
2021-06-30
|
-0.42
|
-0.33
|
0.09
|
21.43%
|
|
2021-03-31
|
-0.38
|
-0.41
|
-0.03
|
-7.89%
|
|
2020-12-31
|
-0.35
|
-0.36
|
-0.01
|
-2.86%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.12
|
|
2021-12-31
|
-1.40
|
|
2020-12-31
|
-1.56
|
|
2019-12-31
|
-1.67
|
|
2018-12-31
|
-1.93
|
|
2017-12-31
|
-1.41
|